COA Available
Weight Management
GLP-1 S
GLP-1 Receptor Agonist
GLP-1 S receptor agonist for significant weight management and improved metabolic control.
Dosage
0.25–2.4 mg once weekly
Half-Life
~7 days
MW
4113.58 g/mol
Select Size
Third-Party Tested
COA Included
Research Grade
Certificate of Analysis Available
Every batch of GLP-1 S includes a full third-party COA documenting purity, potency, and quality.
Research Benefits
- Significant weight reduction
- Improved glycemic control
- Reduced cardiovascular risk
- Decreased appetite
- Improved metabolic markers
- Neuroprotective effects
For research use only. Not for human consumption. Must be 18+ to purchase.
About GLP-1 S
GLP-1 S is a GLP-1 receptor agonist that regulates blood sugar, reduces appetite, and supports significant weight management. Clinical trials show average body weight reductions of 15–20% over extended periods.
Significant weight reduction
Improved glycemic control
Reduced cardiovascular risk
Decreased appetite
Improved metabolic markers
Neuroprotective effects